Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01807897 · ClinicalTrials.gov registry record · Phase 4
Oxygen Versus PAP for Sleep Apnea in Heart Failure
A Phase 4 study of Heart Failure and Sleep Apnea Syndromes, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 4
- Development phase
- 74
- Enrollment target
- 2
- Study locations
NCT01807897 is a Phase 4 study of Heart Failure and Sleep Apnea Syndromes that has completed, run by VA Office of Research and Development. The registered enrollment target is 74 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01807897, a Phase 4 study of Heart Failure and Sleep Apnea Syndromes, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 74 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to compare three treatment modalities for central, or mixed obstructive and central, sleep apnea in patients with chronic heart failure and reduced ejection fraction. The modalities to be tested are nocturnal supplemental oxygen (NSO) and continuous positive airway pressure (CPAP). The main outcome measures will be left ventricular ejection fraction on echocardiogram and peak oxygen consumption on cardiopulmonary exercise testing.
Conditions Studied
Interventions
- DEVICE Continuous positive airway pressure
- DEVICE Nocturnal supplemental oxygen
- BEHAVIORAL Healthy Lifestyle and Sleep Education
Study Locations (2)
Connecticut
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT - West Haven
Massachusetts
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2014-06-23 |
| Est. Completion | 2020-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01807897
The ClinicalTrials.gov registry entry for NCT01807897 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (96% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 3 interventions - of which Continuous positive airway pressure is the first listed.
NCT01807897 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01807897 about?
NCT01807897 is a clinical study titled "Oxygen Versus PAP for Sleep Apnea in Heart Failure". The purpose of this study is to compare three treatment modalities for central, or mixed obstructive and central, sleep apnea in patients with chronic heart failure and reduced ejection fraction. The modalities to be tested are nocturnal supplemental oxygen (NSO) and continuous positive airway press...
What is the current status of trial NCT01807897?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 74 participants. The study started on 2014-06-23. Estimated completion is 2020-06-30.
What conditions does trial NCT01807897 study?
This clinical trial studies the following conditions: Heart Failure, Sleep Apnea Syndromes.
What interventions are being tested in trial NCT01807897?
The interventions under investigation include: Continuous positive airway pressure (DEVICE), Nocturnal supplemental oxygen (DEVICE), Healthy Lifestyle and Sleep Education (BEHAVIORAL).
Who is sponsoring clinical trial NCT01807897?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01807897 being conducted?
This trial has 2 study locations across Connecticut, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure
RECRUITING · Phase 4
-
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
RECRUITING · Phase 4
-
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
RECRUITING · Phase 4
-
The STOP-MED CTRCD Trial
RECRUITING · Phase 4
-
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
RECRUITING · Phase 4
-
Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.